For an adult with severe hyperglycemia (blood glucose 281–515 mg/dL) on insulin glargine (Lantus) 10 units and an insulin drip delivering 0.5 units/hour overnight, what insulin‑sensitivity correction factor and carbohydrate‑to‑insulin ratio should be used?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Insulin Regimen Adjustment for Severe Hyperglycemia on Insulin Drip

This patient requires immediate transition to a scheduled basal-bolus insulin regimen with aggressive dose titration, not continuation of sliding-scale correction doses alone.

Immediate Regimen Changes Required

Calculate Total Daily Dose from IV Insulin Requirements

  • The patient received 10 units of Lantus plus an additional 0.5 units/hour overnight (12 hours) = 6 units, totaling approximately 16 units over 24 hours as a baseline requirement 1.
  • Blood glucose levels of 281–515 mg/dL indicate this dose is grossly inadequate and the patient requires 0.3–0.5 units/kg/day as total daily insulin given the severity of hyperglycemia 1, 2.
  • For severe hyperglycemia with glucose >300 mg/dL, start with a total daily dose of 0.4–0.5 units/kg/day, split 50% as basal insulin and 50% as prandial insulin divided among three meals 1, 2.

Basal Insulin (Lantus) Adjustment

  • Increase Lantus immediately to 0.2–0.25 units/kg/day (approximately 50% of the calculated total daily dose) 1, 2.
  • Titrate basal insulin by 4 units every 3 days if fasting glucose remains ≥180 mg/dL until fasting blood glucose reaches 80–130 mg/dL 1, 2.
  • The current 10 units is insufficient; blood glucose in the 200s–500s mg/dL reflects both inadequate basal coverage AND postprandial excursions requiring mealtime insulin 2.

Prandial Insulin Initiation

  • Start rapid-acting insulin (lispro, aspart, or glulisine) at 4 units before each of the three largest meals, or use 10% of the current basal dose 1, 2.
  • Administer prandial insulin 0–15 minutes before meals for optimal postprandial glucose control 1, 3.
  • Titrate prandial insulin by 1–2 units or 10–15% every 3 days based on 2-hour postprandial glucose readings, targeting postprandial glucose <180 mg/dL 1, 2.

Calculating Correction Factor and Carbohydrate Ratio

Insulin Sensitivity Factor (Correction Factor)

  • Use the formula ISF = 1500 ÷ Total Daily Dose (TDD) for regular insulin or ISF = 1700 ÷ TDD for rapid-acting analogs 1, 4, 5.
  • Once the total daily dose is established (e.g., 40 units/day), the correction factor would be 1500 ÷ 40 = 37.5 mg/dL per unit (meaning 1 unit of insulin lowers blood glucose by approximately 37.5 mg/dL) 1, 4.
  • Recalculate the correction factor every few weeks as the total daily dose changes, not daily 1.

Carbohydrate-to-Insulin Ratio

  • Use the formula CIR = 450 ÷ TDD for rapid-acting insulin analogs or CIR = 500 ÷ TDD for regular insulin 1, 4, 5.
  • For a total daily dose of 40 units, the carbohydrate ratio would be 450 ÷ 40 = 11.25 grams of carbohydrate per 1 unit of insulin 1, 4.
  • CIR has diurnal variance: breakfast typically requires more insulin per gram of carbohydrate (use 300 ÷ TDD), while lunch and dinner require less (use 400 ÷ TDD) 6.
  • A common starting ratio is 1 unit per 10–15 grams of carbohydrate, adjusted based on postprandial glucose patterns 1.

Critical Pitfall: Sliding-Scale Insulin as Monotherapy

  • Sliding-scale insulin as the sole treatment is explicitly condemned by all major diabetes guidelines and should be immediately discontinued 1, 2.
  • Only 38% of patients on sliding-scale alone achieve mean glucose <140 mg/dL, versus 68% with scheduled basal-bolus regimens, with no increased hypoglycemia risk when properly implemented 1.
  • Correction doses are intended only as supplements to scheduled basal and prandial insulin, never as a replacement 1.
  • For correction doses, use 2 units of rapid-acting insulin for pre-meal glucose >250 mg/dL and 4 units for glucose >350 mg/dL, in addition to scheduled doses 1.

Monitoring and Titration Protocol

Daily Monitoring Requirements

  • Check fasting blood glucose every morning during the titration phase to guide basal insulin adjustments 1, 2.
  • Check pre-meal and 2-hour postprandial glucose to guide prandial insulin adjustments 1, 2.
  • For hospitalized patients eating regular meals, check point-of-care glucose before each meal and at bedtime 1.

Hypoglycemia Management

  • If hypoglycemia occurs (glucose <70 mg/dL), treat immediately with 15 grams of fast-acting carbohydrate and reduce the implicated insulin dose by 10–20% 1, 2.
  • Never administer rapid-acting insulin at bedtime as a sole correction dose, as this markedly raises nocturnal hypoglycemia risk 1, 3.

Foundation Therapy Verification

  • Ensure the patient is on metformin (up to 2000–2550 mg daily) unless contraindicated, as this combination provides superior glycemic control with reduced insulin requirements and less weight gain 1, 2.
  • Consider discontinuing sulfonylureas when advancing beyond basal-only insulin to prevent hypoglycemia 1.

Expected Outcomes

  • With appropriate basal-bolus therapy at weight-based dosing, 68% of patients achieve mean blood glucose <140 mg/dL 1.
  • HbA1c reduction of 2–3% is achievable with proper insulin intensification over 3–6 months 1.
  • Target glucose range: fasting/pre-meal 80–130 mg/dL and postprandial <180 mg/dL 1, 2.

References

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Hyperglycemia on Basal Insulin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

EADSG Guidelines: Insulin Therapy in Diabetes.

Diabetes therapy : research, treatment and education of diabetes and related disorders, 2018

Research

How much do I give? Reevaluation of insulin dosing estimation formulas using continuous glucose monitoring.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.